Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.

Difference between revisions of "National Resilience"

From Wikispooks
Jump to navigation Jump to search
(stub)
 
(some expand)
Line 3: Line 3:
 
|sourcewatch=
 
|sourcewatch=
 
|constitutes=
 
|constitutes=
|logo=
+
|logo=National Resilience biotechnologies logo.png
 +
|titular_logo=1
 
|start=2020
 
|start=2020
 
|description=
 
|description=
Line 15: Line 16:
  
 
==Activities==
 
==Activities==
In March 2023, Resilience Resilience received a $410 million loan from [[DoD|Defense Department]].<ref>https://www.fiercepharma.com/manufacturing/white-house-eyes-biomanufacturing-boost-local-producer-national-resilience-adds-410m</ref>
+
National Resilience was founded in [[2020]], with $800 million in capital.<ref name=fiercepharma>https://www.fiercepharma.com/manufacturing/manufacturer-national-resilience-helmed-by-former-novavax-chief-snags-sanofi</ref>
 +
 
 +
In March 2021, Resilience acquired a former [[Sanofi]] manufacturing plant in [[Boston]]. The company established a "network of high-tech, end-to-end manufacturing solutions" to make current and future drugs "quickly, safely, and at scale," Resilience said in a PR-release.<ref name=fiercepharma/>
 +
 
 +
In 2021, Resilience and [[Moderna]] announced an agreement to manufacture "drug substance" for the [[Moderna COVID-19 vaccine]]. Under the terms of the multi-year agreement, Resilience will produce [[mRNA]] for the Moderna COVID-19 vaccine at its facility in Mississauga, [[Ontario]] in [[Canada]], for distribution worldwide.<ref>https://www.businesswire.com/news/home/20210908005677/en/Resilience-to-Manufacture-mRNA-for-Moderna%E2%80%99s-COVID-19-Vaccine</ref>
 +
 
 +
In March 2023, Resilience Resilience received a $410 million loan from [[DoD|Department of Defense]].<ref>https://www.fiercepharma.com/manufacturing/white-house-eyes-biomanufacturing-boost-local-producer-national-resilience-adds-410m</ref>
 +
 
 +
In partnership with the Department of Defense, Resilience manages the DOD Advanced Development and Manufacturing (ADM) facility in [[Alachua, Florida]] as a contractor-owned, contractor-operated end-to-end biomanufacturing facility.<ref>https://resilience.com/engage/govt</ref>
  
 
==People==
 
==People==
Board as of March 2024.<ref>https://resilience.com/meet/team/</ref> Board members include people from the [[Gates Foundation]] and the [[CIA]] ([[In-Q-Tel ]]).
+
Board as of March 2024.<ref>https://resilience.com/meet/team/</ref> Board members include people from the [[Gates Foundation]] and the [[CIA]].
 +
 
 +
Board member [[Susan Desmond-Hellmann]] was former CEO of the [[Gates Foundation]].
 +
 
 +
[[Chris Darby]] is head of the [[CIA]]'s [[In-Q-Tel ]].
  
 +
[[Rahul Singhvi]] was previously was President and CEO of [[Novavax]] and the [[vaccine]] department at [[Takeda Pharmaceuticals]].<ref>https://aibn.uq.edu.au/dr-rahul-singhvi</ref>
  
 +
The company also counts former [[FDA]] commissioner [[Scott Gottlieb]] among its founding board of directors.<ref name=fiercepharma/>
  
 
{{SMWDocs}}
 
{{SMWDocs}}

Revision as of 23:21, 6 March 2024

Group.png National Resilience WebsiteRdf-entity.pngRdf-icon.png
National Resilience biotechnologies logo.png
Formation2020
HeadquartersSan Diego, California, USA
Membership•  Robert Nelsen
•  Patrick Y. Yang
•  Drew Oetting
• Rahul Singhvi.png Rahul Singhvi
•  Frances Arnold
•  George Barrett
•  Mitchell E. Daniels Jr
• Chris Darby.png Chris Darby
• Sue Desmond-Hellmann.jpg Susan Desmond-Hellmann
•  Kaye Foster
• Photo 2021-10-11 16-35-48.jpg Scott Gottlieb
• Senator Bob Kerrey.jpg Joseph Robert Kerrey
•  Denice Torres

National Resilience, Inc is a "technology-focused biomanufacturing company dedicated to broadening access to complex medicines".[1]

Activities

National Resilience was founded in 2020, with $800 million in capital.[2]

In March 2021, Resilience acquired a former Sanofi manufacturing plant in Boston. The company established a "network of high-tech, end-to-end manufacturing solutions" to make current and future drugs "quickly, safely, and at scale," Resilience said in a PR-release.[2]

In 2021, Resilience and Moderna announced an agreement to manufacture "drug substance" for the Moderna COVID-19 vaccine. Under the terms of the multi-year agreement, Resilience will produce mRNA for the Moderna COVID-19 vaccine at its facility in Mississauga, Ontario in Canada, for distribution worldwide.[3]

In March 2023, Resilience Resilience received a $410 million loan from Department of Defense.[4]

In partnership with the Department of Defense, Resilience manages the DOD Advanced Development and Manufacturing (ADM) facility in Alachua, Florida as a contractor-owned, contractor-operated end-to-end biomanufacturing facility.[5]

People

Board as of March 2024.[6] Board members include people from the Gates Foundation and the CIA.

Board member Susan Desmond-Hellmann was former CEO of the Gates Foundation.

Chris Darby is head of the CIA's In-Q-Tel .

Rahul Singhvi was previously was President and CEO of Novavax and the vaccine department at Takeda Pharmaceuticals.[7]

The company also counts former FDA commissioner Scott Gottlieb among its founding board of directors.[2]


 

Known members

4 of the 14 of the members already have pages here:

MemberDescription
Chris Darby
Sue Desmond-HellmannGates Foundation CEO with board positions at OpenAI, Howard Hughes Medical Institute, National Resilience.
Scott GottliebSpooky Food and Drug Administration leader who moved to Pfizer during Covid.
Robert NelsenFounder of National Resilience, Inc., which launched in 2020 with $800 million in capital, and signed a deal to produce hundreds of millions of doses of Moderna's mRNA vaccine
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.


References


57px-Notepad icon.png This is a page stub. Please add to it.